Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting

Laurent Hébert-Dufresne, Benjamin M. Althouse, Samuel V. Scarpino, View ORCID ProfileAntoine Allard
doi: https://doi.org/10.1101/2020.02.10.20021725
Laurent Hébert-Dufresne
1Vermont Complex Systems Center, University of Vermont, Burlington, VT 05405
2Department of Computer Science, University of Vermont, Burlington, VT 05405
3Département de physique, de génie physique et d’optique, Université Laval, Québec (Québec), Canada G1V 0A6
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: laurent.hebert-dufresne@uvm.edu
Benjamin M. Althouse
4Institute for Disease Modeling, Bellevue, WA
5University of Washington, Seattle, WA
6New Mexico State University, Las Cruces, NM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel V. Scarpino
7Network Science Institute, Northeastern University, Boston, MA, 02115
8Department of Marine & Environmental Sciences, Northeastern University, Boston, MA, 02115
9Department of Physics, Northeastern University, Boston, MA, 02115
10Department of Health Sciences, Northeastern University, Boston, MA, 02115
11ISI Foundation, Turin, 10126, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Allard
3Département de physique, de génie physique et d’optique, Université Laval, Québec (Québec), Canada G1V 0A6
12Centre interdisciplinaire en modélisation mathématique, Université Laval, Québec (Québec), Canada G1V 0A6
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antoine Allard
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The basic reproductive number — R0 — is one of the most common and most commonly misapplied numbers in public health. Although often used to compare outbreaks and forecast pandemic risk, this single number belies the complexity that two different pathogens can exhibit, even when they have the same R0 [1–3]. Here, we show how to predict outbreak size using estimates of the distribution of secondary infections, leveraging both its average R0 and the underlying heterogeneity. To do so, we reformulate and extend a classic result from random network theory [4] that relies on contact tracing data to simultaneously determine the first moment (R0) and the higher moments (representing the heterogeneity) in the distribution of secondary infections. Further, we show the different ways in which this framework can be implemented in the data-scarce reality of emerging pathogens. Lastly, we demonstrate that without data on the heterogeneity in secondary infections for emerging infectious diseases like COVID-19, the uncertainty in outbreak size ranges dramatically. Taken together, our work highlights the critical need for contact tracing during emerging infectious disease outbreaks and the need to look beyond R0 when predicting epidemic size.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The National Institutes of Health 1P20 GM125498-01 Centers of Biomedical Research Excellence Award; the Bill and Melinda Gates through the Global Good Fund; Northeastern University; the Sentinelle Nord initiative of the Canada First Research Excellence Fund; the Natural Sciences and Engineering Research Council of Canada (project 2019-05183)

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Non applicable

https://github.com/Emergent-Epidemics/beyond_R0

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted April 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting
Laurent Hébert-Dufresne, Benjamin M. Althouse, Samuel V. Scarpino, Antoine Allard
medRxiv 2020.02.10.20021725; doi: https://doi.org/10.1101/2020.02.10.20021725
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting
Laurent Hébert-Dufresne, Benjamin M. Althouse, Samuel V. Scarpino, Antoine Allard
medRxiv 2020.02.10.20021725; doi: https://doi.org/10.1101/2020.02.10.20021725

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1950)
  • Dentistry and Oral Medicine (253)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11114)
  • Forensic Medicine (8)
  • Gastroenterology (628)
  • Genetic and Genomic Medicine (3189)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2046)
  • Health Policy (864)
  • Health Systems and Quality Improvement (783)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12733)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2996)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1559)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2792)
  • Public and Global Health (5604)
  • Radiology and Imaging (1096)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (763)
  • Rheumatology (340)
  • Sexual and Reproductive Health (312)
  • Sports Medicine (289)
  • Surgery (346)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)